Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma

BACKGROUND: Methotrexate (MTX), one of the main drugs used to treat osteosarcoma, is a representative folic acid antagonist. Polymorphisms of various enzymes involved in the metabolism of MTX could contribute to differences in response to MTX in pediatric osteosarcoma patients. METHODS: Blood and ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jeong A, Shin, Hee Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828529/
https://www.ncbi.nlm.nih.gov/pubmed/27104192
http://dx.doi.org/10.5045/br.2016.51.1.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828529/
https://www.ncbi.nlm.nih.gov/pubmed/27104192
http://dx.doi.org/10.5045/br.2016.51.1.50

Ejemplares similares